855 related articles for article (PubMed ID: 12591746)
1. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
2. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
4. Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance.
Zolk O; Ng LL; O'Brien RJ; Weyand M; Eschenhagen T
Circulation; 2002 Sep; 106(12):1442-6. PubMed ID: 12234945
[TBL] [Abstract][Full Text] [Related]
5. What are appropriate controls for cardiac interleukin-6 expression in heart failure?
Plenz GA; Eschert H; Deng MC
Circulation; 2003 Oct; 108(17):e129-30; author reply e129-30. PubMed ID: 14581394
[No Abstract] [Full Text] [Related]
6. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
7. Signaling of type II oncostatin M receptor.
Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H
J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471
[TBL] [Abstract][Full Text] [Related]
8. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
10. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
[TBL] [Abstract][Full Text] [Related]
11. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
12. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?
Sriram K; Benkovic SA; Hebert MA; Miller DB; O'Callaghan JP
J Biol Chem; 2004 May; 279(19):19936-47. PubMed ID: 14996842
[TBL] [Abstract][Full Text] [Related]
13. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
14. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
15. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
16. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
[TBL] [Abstract][Full Text] [Related]
17. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
[TBL] [Abstract][Full Text] [Related]
19. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
Pan J; Fukuda K; Saito M; Matsuzaki J; Kodama H; Sano M; Takahashi T; Kato T; Ogawa S
Circ Res; 1999 May; 84(10):1127-36. PubMed ID: 10347087
[TBL] [Abstract][Full Text] [Related]
20. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.
Stahl N; Farruggella TJ; Boulton TG; Zhong Z; Darnell JE; Yancopoulos GD
Science; 1995 Mar; 267(5202):1349-53. PubMed ID: 7871433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
